Silverlake Wealth Management LLC Takes $844,000 Position in CVS Health Corporation $CVS

Silverlake Wealth Management LLC purchased a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 8,159 shares of the pharmacy operator’s stock, valued at approximately $844,000.

A number of other institutional investors also recently bought and sold shares of the stock. Caitong International Asset Management Co. Ltd grew its holdings in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the period. Swiss RE Ltd. purchased a new position in shares of CVS Health in the 4th quarter valued at approximately $26,000. Mcguire Capital Advisors Inc. purchased a new position in shares of CVS Health in the 4th quarter valued at approximately $28,000. Sankala Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at approximately $28,000. Finally, Global Trust Asset Management LLC grew its stake in CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 300 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CVS Health news, Director Larry Robbins sold 370,462 shares of the firm’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. This trade represents a 7.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last quarter, insiders have sold 3,372,000 shares of company stock worth $317,473,598. Corporate insiders own 0.85% of the company’s stock.

CVS Health Stock Up 2.2%

CVS stock opened at $97.09 on Friday. The business has a 50 day moving average of $102.52 and a 200 day moving average of $88.23. The firm has a market cap of $124.18 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 0.93 and a beta of 0.61. CVS Health Corporation has a twelve month low of $67.42 and a twelve month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the company posted $1.81 earnings per share. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.7%. CVS Health’s payout ratio is presently 70.37%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. DA Davidson increased their price objective on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Weiss Ratings upgraded shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, August 5th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday. Piper Sandler reiterated an “overweight” rating and issued a $113.00 price target on shares of CVS Health in a research note on Monday, June 1st. Finally, Cantor Fitzgerald boosted their price objective on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $106.75.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.